WOLFF STEFANI (Senior VP of Strategy and Ops) sold 13.4% of their position (5.50K shares) of PRINCIPIA BIOPHARMA INC. on the open market
Open‑market sale worth $272.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/18/2019ACC: 0001209191-19-061189
Officer· Senior VP of Strategy and Ops
Since Sep 2018
-5.50K
Net shares
Net seller
$272.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5.50K acquired · 11.01K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.50K
Price / share
$4.54
Trade value
$25K
% of position
15.5%
12/16/2019
35.61K→41.11K
Common Stock
Direct
Shares
−4.21K
Price / share
$49.29
Trade value
$207.27K
% of position
10.2%
12/16/2019
41.11K→36.91K
Common Stock
Direct
Shares
−1.30K
Price / share
$49.87
Trade value
$64.83K
% of position
3.5%
12/16/2019
36.91K→35.61K
Total
Net shares
+0.00
Net value
-$247.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2019 | M · Option Exercise | +5.50K | $4.54 | $25K | 15.5% | 35.61K | 41.11K |
| Common Stock Direct | 12/16/2019 | S · Sale | −4.21K | $49.29 | $207.27K | 10.2% | 41.11K | 36.91K |
| Common Stock Direct | 12/16/2019 | S · Sale | −1.30K | $49.87 | $64.83K | 3.5% | 36.91K | 35.61K |
| Total | +0.00 | -$247.09K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
4.542
Held after
24.55K
Exercisable
—
12/16/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5.50K shares | 12/16/2019 | M · Option Exercise | −5.50K | 4.542 | — | 24.55K |